Application of a liquid chromatography-tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion studies of Dactylicapnos scandens in rats

被引:25
作者
Guo, Changchuan [1 ]
Jiang, Yan [1 ]
Li, Li [1 ]
Hong, Lan [2 ]
Wang, Yuqing [1 ]
Shen, Qian [1 ]
Lou, Yan [3 ]
Hu, Haihong [1 ]
Zhou, Hui [1 ]
Yu, Lushan [1 ]
Jiang, Huidi [1 ]
Zeng, Su [1 ]
机构
[1] Zhejiang Univ, Coll Pharmaceut Sci, Dept Pharmaceut Anal & Drug Metab, Hangzhou 310058, Zhejiang, Peoples R China
[2] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA
[3] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou 310000, Zhejiang, Peoples R China
关键词
Dactylicapnos scandens; Pharmacokinetics; Tissue distribution; Excretion; Isocorydine; Protopine; BIOAVAILABILITY; INHIBITOR;
D O I
10.1016/j.jpba.2012.10.011
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The herbal ingredients of isocorydine and protopine were isolated from Dactylicapnos scandens. This study was aimed at developing a liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) method to quantify isocorydine and protopine in rat plasma and tissues for pharmacokinetic, tissue distribution and excretion studies. Biological samples were processed with ethyl acetate extraction, and corydaline was chosen as the internal standard (IS). The analytes were separated by a C-18 column and detected with a triple quadrupole mass spectrometer using positive ion ESI in the multiple reaction monitoring (MRM) mode. The MS/MS ion transitions monitored were m/z 342.0 -> 278.9 for isocorydine, 354.1 -> 188.0 for protopine and 370.0 -> 192.0 for IS, respectively. Excellent linearity was observed over the concentration range between 10 and 3000 ng/mL for isocorydine and 10-300 ng/mL for protopine. The lower limit of quantification (LLOQ) was 10 ng/mL for both isocorydine and protopine. This novel method was rapid, accurate, high sensitive and high selective. It was successfully applied to the pharmacokinetic, tissue distribution and excretion studies of D. scandens. These preclinical data of D. scandens would be useful for the clinical reference. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:92 / 100
页数:9
相关论文
共 17 条
[1]  
[Anonymous], 2013, Guidance for industry, bioanalytical method validation
[2]  
Bencao Zhonghua, 1999, ZHONGH BENC
[3]   Pre-clinical assessment of DRF 4367, a novel COX-2 inhibitor:: Evaluation of pharmacokinetics, absolute oral bioavailability and metabolism in mice and comparative inter-species in vitro metabolism [J].
Bhamidipati, R ;
Mujeeb, S ;
Dravid, PV ;
Khan, AA ;
Singh, SK ;
Rao, YK ;
Mullangi, R ;
Srinivas, NR .
XENOBIOTICA, 2005, 35 (03) :253-271
[4]   Overcoming Matrix Effects in Liquid Chromatography-Mass Spectrometry [J].
Cappiello, Achille ;
Famiglini, Giorgio ;
Palma, Pierangela ;
Pierini, Elisabetta ;
Termopoli, Veronica ;
Trufelli, Helga .
ANALYTICAL CHEMISTRY, 2008, 80 (23) :9343-9348
[5]   Analysis and determination of diterpenoids in unprocessed and processed Euphorbia lathyris seeds by HPLC-ESI-MS [J].
Hou, Xiao-Rong ;
Wan, Lei-Lei ;
Zhan, Zha-Jun ;
Li, Cheng-Ping ;
Shan, Wei-Guang .
JOURNAL OF PHARMACEUTICAL ANALYSIS, 2011, 1 (03) :197-202
[6]   LC-MS determination and pharmacokinetic study of salidroside in rat plasma after oral administration of suspensions of traditional Chinese medicine Erzhi Wan and Fructus Ligustri lucidi [J].
Li, Ze-Yun ;
Li, Qing ;
Lu, Jiang ;
Ling, Jun-Hong ;
Yu, Xi-Hua ;
Chen, Xiao-Hui ;
Bi, Kai-Shun .
JOURNAL OF PHARMACEUTICAL ANALYSIS, 2011, 1 (01) :8-12
[7]   Simultaneous determination of tetrahydropalmatine, protopine, and palmatine in rat plasma by LC-ESI-MS and its application to a pharmacokinetic study [J].
Ma, Hongda ;
Wang, Yongjun ;
Guo, Tao ;
He, Zhonggui ;
Chang, Xinyu ;
Pu, Xiaohui .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 49 (02) :440-446
[8]   Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS [J].
Matuszewski, BK ;
Constanzer, ML ;
Chavez-Eng, CM .
ANALYTICAL CHEMISTRY, 2003, 75 (13) :3019-3030
[9]  
The National Traditional Chinese Medicines Compile Group, 1996, NAT TRAD CHIN MED CO
[10]   The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat [J].
Treiber, A. ;
Morand, O. ;
Clozel, M. .
XENOBIOTICA, 2007, 37 (03) :298-314